These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 16652429

  • 1. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.
    Urakami T, Manki A, Inoue T, Oda M, Tanaka H, Morishima T.
    J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429
    [Abstract] [Full Text] [Related]

  • 2. Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.
    Bjørnhart B, Juul A, Nielsen S, Zak M, Svenningsen P, Müller K.
    J Rheumatol; 2009 Aug; 36(8):1749-54. PubMed ID: 19605679
    [Abstract] [Full Text] [Related]

  • 3. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K, Kawakami A, Tamai M, Uetani M, Takao S, Arima K, Iwamoto N, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K.
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [Abstract] [Full Text] [Related]

  • 4. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
    el-Gamal YM, Heshmat NM, el-Kerdany TH, Fawzy AF.
    Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
    [Abstract] [Full Text] [Related]

  • 5. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S.
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [Abstract] [Full Text] [Related]

  • 6. [Composition of linoleic and arachidonic acids in phosphatidylcholine of erythrocytes membrane and IL-6 and TNF-alpha in serum and C-reactive protein concentration in children with juvenile idiopathic arthritis].
    Górska A, Urban M, Pietrewicz E, Górski S.
    Pol Merkur Lekarski; 2006 Dec; 21(126):551-3. PubMed ID: 17405296
    [Abstract] [Full Text] [Related]

  • 7. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.
    Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, Roth J.
    Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102
    [Abstract] [Full Text] [Related]

  • 8. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
    Nakajima S, Naruto T, Miyamae T, Imagawa T, Mori M, Nishimaki S, Yokota S.
    Mod Rheumatol; 2009 Mar; 19(1):42-6. PubMed ID: 18726067
    [Abstract] [Full Text] [Related]

  • 9. Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
    Crnkic M, Månsson B, Larsson L, Geborek P, Heinegård D, Saxne T.
    Arthritis Res Ther; 2003 Mar; 5(4):R181-5. PubMed ID: 12823852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
    Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W.
    Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
    [Abstract] [Full Text] [Related]

  • 15. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
    Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, Foster HE.
    Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
    [Abstract] [Full Text] [Related]

  • 16. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
    Bloom BJ, Nelson SM, Eisenberg D, Alario AJ.
    J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
    [Abstract] [Full Text] [Related]

  • 17. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
    Vilim V, Lenz ME, Vytasek R, Masuda K, Pavelka K, Kuettner KE, Thonar EJ.
    Arch Biochem Biophys; 1997 May 01; 341(1):8-16. PubMed ID: 9143347
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis].
    Li H, Wang D, Wu ZQ, Zhong JM, Yuan YJ.
    Zhongguo Gu Shang; 2012 May 01; 25(5):380-3. PubMed ID: 22870681
    [Abstract] [Full Text] [Related]

  • 19. Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides.
    Gattorno M, Vignola S, Falcini F, Sabatini F, Buoncompagni A, Simonini G, Picco P, Pistoia V.
    J Rheumatol; 2002 Apr 01; 29(4):826-31. PubMed ID: 11950028
    [Abstract] [Full Text] [Related]

  • 20. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.
    Weitoft T, Larsson A, Saxne T, Rönnblom L.
    Ann Rheum Dis; 2005 Dec 01; 64(12):1750-3. PubMed ID: 15843449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.